A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19

The alarming pandemic situation of novel Severe Acute Respiratory Syndrome Coronavirus 2 (nSARS-CoV-2) infection, high drug development cost and slow process of drug discovery have made repositioning of existing drugs for therapeutics a popular alternative. It involves the repurposing of existing sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Pankaj, Varshney, Rajeev, Gupta, Apoorv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093055/
https://www.ncbi.nlm.nih.gov/pubmed/35578630
http://dx.doi.org/10.1016/j.heliyon.2022.e09387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093055/
https://www.ncbi.nlm.nih.gov/pubmed/35578630
http://dx.doi.org/10.1016/j.heliyon.2022.e09387

Ejemplares similares